Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Member count: 11-50
Total raised: $10M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Paul Gross... | paulgrossi... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 06.09.2017 | Seed | $10M | - | citybizlis... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 07.09.2017 | Term Sheet... | SPORTS TALK Good morning, Ter... | - | - | fortune.co... |
| 06.09.2017 | Excision B... | Excision BioTherapeutics, a li... | - | - | citybizlis... |
| 06.09.2017 | Excision B... | Excision BioTherapeutics, a Ph... | USA | - | finsmes.co... |